Login / Signup

Background incidence rates of health outcomes of interest for COVID-19 vaccine safety monitoring in a US population: a claims database analysis.

Sonja Gandhi-BangaAlena KhromavaLaurence SerradellAnne-Laure ChabanonChunshen PanIrisdaly EstevezSamantha SchilskyHannah Kreisberg
Published in: BMJ open (2024)
These observations help contextualise fluctuations in background rates of adverse events noted during the COVID-19 era, and provide insight on how their use may impact safety surveillance for other vaccines.
Keyphrases
  • coronavirus disease
  • sars cov
  • public health
  • risk factors
  • health insurance
  • respiratory syndrome coronavirus
  • adverse drug